Project: Innovating point-of-care diagnostics for the early and rapid detection of invasive fungal pathogens
Pasricha Group
Invasive fungal disease (IFD) poses comorbidity challenges for cancer patients, increasing mortality. IFD is difficult to diagnose, diagnostics are few, expensive and show low sensitivity. There are no bedside, rapid point-of-care tests (PoCTs) for the detection of invasive fungi . Our team has successfully applied CRISPR-technology for PoCTs that are sensitive and fast. This project aims to develop a CRISPR-PoCT for the detection of invasive aspergillosis. Such innovation can improve screening during cancer treatment, provide early detection, enable precision medicine, and be a test of cure.
Contact project supervisor for further
information and application enquiries
Pasricha Group
1 vacancies
The Pasricha Lab is passionate about developing and improving diagnostic tools for the detection of infectious diseases. With a heavy emphasis on translational research, we hope to see our research contribute to early diagnosis and improved disease control and surveillance. We work closely with clinicians, laboratory scientists at the Victorian Infectious Diseases Reference Laboratory (VIDRL) and industry partners on infectious diseases who need real-time responses. All students are mentored by multiple members of our team, experts in bioinformatic analysis, microbiology and molecular laboratory techniques. Our students are also given the opportunity to present their work to collaborators and clinicians.
Pasricha Group Current Projects
-
Innovating point-of-care diagnostics for the early and rapid detection of invasive fungal pathogens
PhD/MPhil, Master of Biomedical Science
-
Transforming infectious disease diagnostics with human biomarkers of infection
PhD/MPhil
-
Enhancing HIV management and HIV cure research through CRISPR-based viral load testing at the point of care
PhD/MPhil, Master of Biomedical Science
Research degrees at the Doherty Institute are administered by the University of Melbourne.